Hepatitis Newswire (Page 2)

Hepatitis Newswire (Page 2)

Comprehensive Real-Time News Feed for Hepatitis. (Page 2)

Results 21 - 40 of 6,446 in Hepatitis

  1. Global Hepatitis C Drug Market: Study Provides Historic Data of...Read the original story w/Photo

    Monday | SBWire

    The report covers forecast and analysis for the market on a global and regional level. According to the report, global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, is expected to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% between 2016 and 2021.

    Comment?

  2. Drs. Oz & Roizen: Returning to school can cause headachesRead the original story

    Monday | Athens Banner-Herald

    ... can be very worthwhile for both of you. The Virginia Department of Health issued a warning about an outbreak of hepatitis A because of smoothies from a national chain. How is it possible to get hepatitis from a smoothie? You can get hepatitis A from ...

    Comment?

  3. Dalhousie University's Molly Appeal raising money for immunity researchRead the original story w/Photo

    Monday | CBC News

    Dr. Lisa Barrett says it's possible to cure a Hepatitis C patient and observe how their immune system goes from compromised to functioning, in the hopes of applying those lessons to an aging person. An infectious diseases specialist at Dalhousie Medical School in Halifax is looking to raise money for a new machine that could help her study the cells of Hepatitis C patients in the P.E.I prison system, as a way to better understand the immune system.

    Comment?

  4. Medivir: Updated Interim Phase IIa Data Demonstrate That The...Read the original story

    Sunday Sep 25 | BioSpace

    "Short duration treatment with AL-335 and odalasvir , with or without simeprevir , in treatment naive patients with hepatitis C virus genotype 1 infection." Medivir AB today announced that updated interim data from a phase IIa study being conducted by Alios BioPharma Inc., part of the Janssen Pharmaceutical Companies , were presented on September 23rd at the European Association for the Study of the Liver Special Conference in Paris, France.

    Comment?

  5. Find out more about the awards in our blogRead the original story w/Photo

    Monday | Aidsmap

    ... with information on formulation, dosing, key side-effects and food restrictions. Two of NAM's booklets, HIV & hepatitis and HIV, mental health & emotional wellbeing , have been highly commended at the British Medical Association (BMA) Patient ...

    Comment?

  6. Analysts Set Arrowhead Research Corp. (NASDAQ:ARWR) Price Target at $10.11Read the original story w/Photo

    Sunday | Daily Political

    ... products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA. ARC-520 is designed to treat chronic hepatitis B virus (HBV) infection. Receive News & Ratings for Arrowhead Research Corp. Daily - Enter your email address below to receive ...

    Comment?

  7. Adults in Las Vegas need to keep up on vaccines to stay healthy, tooRead the original story w/Photo

    Sunday | Las Vegas Review Journal

    ... your arm for a few other shots you may not have thought of in years. Shots for whooping cough. Tetanus. Pneumonia. Hepatitis. Even vaccines of relatively recent vintage, such as that for HPV, or human papillomavirus. Most adults probably think of ...

    Comment?

  8. Aluminum in vaccines causes damage to the brain and nervous systemRead the original story w/Photo

    Sunday | NewsTarget.com

    ... can cause kidney failure in premature infants or those with kidney problems. So how much aluminum is in the hepatitis B vaccine, which the Centers for Disease Control and Prevention (CDC) recommend giving to babies on the day they are born? A ...

    Comment?

  9. Achillion Announces 100% SVR12 In The 6-Week And 8-Week Cohorts In...Read the original story

    Sunday Sep 25 | BioSpace

    Achillion Announces 100% SVR12 In The 6-Week And 8-Week Cohorts In Janssen's Phase II Trial Evaluating The Triple Combination Treatment Regimen Including Odalasvir, AL-335, And Simeprevir For Genotype 1 Treatment-NaA ve HCV - ePoster presented today at the EASL / AASLD Special Conference: New Perspectives in Hepatitis C Virus Infection - The Roadmap For Cure - - Ongoing Phase 2 development focusing on triple combination for treatment durations as short as six weeks for broad HCV population - PARIS, Sept.

    Comment?

  10. UVLrx Therapy Lights Up Charlatans Dealing In Medical Devices, UVLrx Therapeutics RevealsRead the original story

    Sunday Sep 25 | BioSpace

    ... lessen inflammation. Research with the device is supposedly underway in Cameroon to treat HIV/AIDS, in Egypt for hepatitis C and in the Philippines for Dengue Fever. Paul LeMert, the managing director of UVLrx Therapeutics, stated last year in ...

    Comment?

  11. Adults need to keep up on vaccines to stay healthy, tooRead the original story w/Photo

    Sunday | Las Vegas Review Journal

    ... your arm for a few other shots you may not have thought of in years. Shots for whooping cough. Tetanus. Pneumonia. Hepatitis. Even vaccines of relatively recent vintage, such as that for HPV, or human papillomavirus. Most adults probably think of ...

    Comment?

  12. Why a Zika vaccine is a long way offRead the original story w/Photo

    Sunday | Norwalk Citizen News

    ... to the immune system to trigger an immune response. These types of vaccines can work in two ways. Some, such as hepatitis B vaccine, use injections of the whole outer virus shell to start the immune response. Others use just a small piece of DNA ...

    Comment?

  13. Prevention of progression to cirrhosis in hepatitis C with fibrosisRead the original story

    Sunday Sep 25 | GastroHep.com

    The most recent publication of the Alimentary Pharmacology & Therapeutics evaluates the effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals to prevent progression to cirrhosis in Hep C. The new direct-acting anti-virals for hepatitis C virus infection offer higher cure rates, but at a much higher cost than the standard interferon-based treatments. Dr Faria and colleagues from the United Kingdom identified the cost-effective treatment for patients with HCV infection with F3 liver fibrosis who are at high risk of progression to cirrhosis.

    Comment?

  14. Montana salad bar possibly served hepatitis A to customers for almost an entire monthRead the original story w/Photo

    Saturday Sep 24 | NewsTarget.com

    An unknown number of residents living in Missoula, Montana, may have been exposed to Hepatitis A, a viral liver disease that may result in mild to severe illness, according to the World Health Organization . The possible transmission may have occurred due to an infected employee who was tending a salad bar at a restaurant called Good Food Store.

    Comment?

  15. ICU Medical Inc. (ICUI) Cut to "Hold" at Zacks Investment ResearchRead the original story w/Photo

    Saturday Sep 24 | AmericanBankingNews.com

    According to Zacks, "ICU Medical, Inc., together with its wholly-owned subsidiary Budget Medical Products, Inc. is a leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in intravenous therapy applications. The company's intravenous connectors are designed to prevent accidental disconnection's of intravenous lines and to protect healthcare workers and their patients from the spread of infectious diseases such as Hepatitis B and Human Immunodeficiency Virus by significantly reducing the risk of accidental needlesticks.

    Comment?

  16. 104 Hepatitis A cases reported in Virginia due to Tropical Smoothie outbreakRead the original story w/Photo

    Saturday Sep 24 | WRIC-TV Richmond

    The Virginia Department of Health is reporting that the total number of Hepatitis A cases in Virginia has increased to 104. Richmond isn't just another average city -- it's a great place to live, work, play, and love.

    Comment?

  17. New York-Presbyterian/Lawrence Hospital Recognized by NY State Department of HealthRead the original story w/Photo

    Saturday Sep 24 | New Rochelle Talk

    NewYork-Presbyterian/Lawrence Hospital is pleased to announce it is one of only twenty-five hospitals to be recognized by The New York State Department of Health Bureau of Immunization Perinatal Hepatitis B Prevention Program. The hospital has been placed on the Immunization Action Coalition Birth Dose Honor Roll by achieving a 90% or higher coverage rate in 2015 for the birth dose of hepatitis B vaccine and also passed their most recent lot quality assurance visit.

    Comment?

  18. Global study assesses countries on health-related Sustainable Development GoalsRead the original story w/Photo

    Saturday Sep 24 | Medical News

    ... came to an end in 2015, few inroads have been made. For example, there have been only minimal improvements in hepatitis B incidence rates, while childhood overweight, intimate partner violence, and harmful alcohol consumption have worsened. The new ...

    Comment?

  19. Hep C and the false economy of the health care system: FioritoRead the original story w/Photo

    Saturday Sep 24 | The Toronto Star

    There is a remarkable drug which treats Hepatitis C. It's expensive, and it works, but you can't get it until you get really sick. A specific medication for the treatment of Hepatitis C costs in the range of $100,000 for a 12-week course of treatments, and, as Joe Fiorito writes, it is not an option for patients until Stage 2, or chronic liver disease.

    Comment?

  20. Analysts Set $16.00 Price Target for Assembly Biosciences Inc.Read the original story w/Photo

    Saturday Sep 24 | Daily Political

    ... in developing approximately two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral biological therapeutics, which are designed to restore health to a dysbiotic ...

    Comment?